Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts
with the healthcare system, immunocompromised state from cancer or its therapies …

Background The COVID-19 pandemic hit all over the world, and cancer patients are more
vulnerable for COVID-19. The mortality rate may increase up to 25% in solid malignancies …

PURPOSE To provide standards and practice recommendations specific to telehealth in
oncology. METHODS A systematic review of the literature on telehealth in oncology was …

Background The onset of the COVID-19 pandemic forced the Dutch national screening
program to a halt and increased the burden on health care services, necessitating the …

Importance To our knowledge, little is known about antibody development after SARS-CoV-
2 vaccination in immunocompromised individuals, such as patients with cancer. Objective …

Abstracts Introduction During the COVID-19 pandemic, teleconsultation was implemented in
clinical practice to limit patient exposure to COVID-19 while monitoring their treatment and …

Introduction COVID-19 has disrupted the global health care system since March 2020. Lung
cancer (LC) patients (pts) represent a vulnerable population highly affected by the …

Starting in Wuhan, China, followed quickly in the United States in January 2020, an outbreak
of a novel coronavirus, or COVID-19, escalated to a global pandemic by March. Significant …

Introduction Individuals with an underlying malignancy have high risk of poor COVID-19
outcomes. In clinical trials, COVID-19 vaccines were safe and efficacious against infection …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …